Sun Pharma signs Definitive Agreement to Acquire Organon
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- Wall St set for higher open as investors weigh Mideast negotiations
- Oil falls after US-Iran talks signal easing supply risks
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
- Sanuwave cuts Q2 2026 revenue guidance amid Ultramist sales pressure
BNP Paribas Exane Downgrades Organon & Co. (OGN) to Neutral Post Acquisition
April 28, 2026 6:17 AM EDTBNP Paribas Exane analyst Navaan Ty downgraded Organon & Co. (NYSE: OGN) from Outperform to Neutral.
For an analyst ratings summary and ratings history on Organon & Co. click here. For more ratings news on Organon & Co. click here.
Shares of Organon & Co. closed at $13.16 yesterday.
... More